Mario Rivas - Nov 17, 2022 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
Chief Executive Officer, Director
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Stock symbol
TGAN
Transactions as of
Nov 17, 2022
Transactions value $
-$20,262
Form type
4
Date filed
11/21/2022, 03:16 PM
Previous filing
Jan 4, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Sale -$20.3K -3.57K -2.93% $5.67 118K Nov 17, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
F2 This sale price represents the weighted average sale price of the shares sold ranging from $5.45 to $5.98 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.